Physician profile
Jay D Carpenter
NPI 1184060881
$9,783.18
in general payments reported to CMS, 2019-2025
35 companies · $767 in 2025
The $767 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $798 · 2020: $282 · 2021: $1,913 · 2022: $3,924 · 2023: $795 · 2024: $1,305 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,329 · Travel and Lodging: $492 · Education: $45.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,328.95 |
| Travel and Lodging | $492.48 |
| Education | $45.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $3,395.86 | 2020-2024 | Axonics, Bulkamid |
| Coloplast Corp | $1,342.24 | 2019-2023 | Altis, Titan |
| Procept Biorobotics Corporation | $895.19 | 2024-2025 | Aquabeam System |
| Neotract INC. | $783.83 | 2019-2020 | |
| Medtronic, INC. | $641.32 | 2021-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $452.38 | 2019-2025 | Lithovue, General - Erectile Dysfunction, Bulkamid |
| Teleflex LLC | $286.17 | 2022-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $240.13 | 2020-2023 | Xtandi |
| Janssen Biotech, INC. | $239.67 | 2020-2025 | Carvykti, Rybrevant, Erleada |
| Sumitomo Pharma America, INC. | $170.90 | 2025 | Gemtesa |
| Rochester Medical Corporation | $169.00 | 2022 | |
| Endo Pharmaceuticals INC. | $142.80 | 2021-2023 | Xiaflex, Aveed, Edex |
| Innovation Technologies INC | $137.30 | 2023-2025 | Irrisept |
| Laborie Medical Technologies Corp. | $119.10 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $95.25 | 2023-2024 | Itind System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $93.54 | 2021-2023 | Xyosted, Tlando, Nocdurna |
| Endo USA, INC. | $81.85 | 2024-2025 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $63.80 | 2022-2023 | |
| Pfizer INC. | $56.77 | 2022 | |
| Astellas Pharma Global Development | $45.50 | 2023 | Xtandi |
| Valencia Technologies Corporation | $37.24 | 2025 | Ecoin Device Kit |
| Menarini Silicon Biosystems, INC. | $34.93 | 2023 | Cellsearch |
| Dendreon Pharmaceuticals LLC | $34.60 | 2025 | Provenge |
| Mimedx Group, INC. | $32.28 | 2024 | |
| Immunitybio, INC. | $29.55 | 2025 | |
| Merck Sharp & Dohme LLC | $22.06 | 2022 | |
| Eisai INC. | $21.14 | 2022 | |
| Progenics Pharmaceuticals, INC. | $19.47 | 2024 | |
| Hollister Incorporated | $19.39 | 2022 | |
| Urogen Pharma, INC. | $19.38 | 2025 | |
| Abbvie INC. | $15.33 | 2023 | Botox |
| Novartis Pharmaceuticals Corporation | $14.47 | 2025 | |
| Clarus Therapeutics INC. | $13.40 | 2021 | |
| Travere Therapeutics, INC. | $12.12 | 2022 | |
| Civco Medical Instruments | $5.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.